Fosaprepitant and Novoeight recombinant
Determining the interaction of Fosaprepitant and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: n.a.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant-Novolin 70/30
- Fosaprepitant-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Fosaprepitant-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Fosaprepitant-Novolin N
- Fosaprepitant-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Fosaprepitant-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Fosaprepitant Injection
- Novoeight recombinant-Fosaprepitant Intravenous
- Novoeight recombinant-Foscarnet
- Novoeight recombinant-Foscarnet Intravenous
- Novoeight recombinant-Foscarnet Sodium
- Novoeight recombinant-Foscavir